August, 2010
eMagine launches redesigned website for Vaccinex
eMagine is proud to announce the launch of a redesigned website for Vaccinex a privately held biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases: www.vaccinex.com
eMagine is proud to announce the launch of a redesigned website for Vaccinex a privately held biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases: http://www.vaccinex.com/